Health Resources and Services Administration: HIV Care Grant Program, Part B
Page 2

f) health insurance premium and cost sharing assistance

g) home health care

h) medical nutrition therapy

i) hospice services

j) home and community-based health services

k) mental health services and medical case management

l) treatment adherence services

m) and substance abuse outpatient care.

The HRSA has an anticipated allocated budget amounting to $1.2 billion for Part B of the HIV Care Grant Program.

To know more about this program, kindly visit Topgovernmentgrants.com or the Grants.gov website.

The following states and territories will be deemed eligible to apply for the HIV Care Grant Program Part B:

a) all 50 states of the USA

b) the District of Columbia

c) the Commonwealth of Puerto Rico

d) the Commonwealth of the Virgin Islands

e) Guam

f) American Samoa

g) the Commonwealth of the Northern Mariana Island

h) the Republic of Palau

i) the Federated States of Micronesia

j) and the Republic of the Marshall Island

The Department of Health and Human Services, the main agency funding the HIV Care Grant Program, is the federal government's leading agency responsible for protecting the health and wellness of every American and providing all essential human services to all, especially to those are least able to help themselves.

Health Resources and Services Administration: HIV Care Grant Program, Part B
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Human Health and Heredity in Africa: Research Grants Program
The Human Health and Heredity in Africa: Research Grants Program wherein they intend to invite applications from foreign institutions that are based in African countries who have the desire to conduct scientific studies regarding the genomic/genetic/environmental contributors of human health and diseases which are common in Africa.

---